Cytochrome P450 1A1 and Cytochrome P450 3A4 (CYP1A1/3A4)

Cytochrome P450 1A1 (CYP1A1) and Cytochrome P450 3A4 (CYP3A4) are essential heme-thiolate monooxygenases belonging to the cytochrome P450 superfamily, playing pivotal roles in the oxidative metabolism of both endogenous and exogenous compounds. CYP3A4 is the most significant drug-metabolizing enzyme in humans, localized primarily in the liver and small intestine, where it processes over 50% of all prescribed medications. CYP1A1 is mainly expressed in extrahepatic tissues like the lungs and placenta and is highly inducible by environmental toxins, such as polycyclic aromatic hydrocarbons, through the aryl hydrocarbon receptor (AhR) pathway. Both enzymes are involved in the detoxification of drugs but can also bioactivate certain compounds into highly reactive, carcinogenic, or toxic intermediates. For instance, CYP1A1 is known for converting benzo[a]pyrene into DNA-reactive epoxides, while CYP3A4 can activate pro-drugs or produce toxic metabolites from agents like acetaminophen. Their activity is a major determinant of drug pharmacokinetics, and their inhibition or induction by various substances leads to significant drug-drug interactions. Understanding the interplay between these enzymes is crucial for predicting drug efficacy, safety, and individual risk for chemically induced diseases.

Other names

Aryl hydrocarbon hydroxylase (CYP1A1)Nifedipine oxidase (CYP3A4)Cytochrome P450-C1Cytochrome P450-PCN1HLPAHHCYPIIIA4

Catalyzes the oxidative biotransformation (hydroxylation, epoxidation, N- and O-dealkylation) of diverse substrates using NADPH as an electron donor and molecular oxygen.